Log in to save to my catalogue

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing prolif...

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing prolif...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3975845

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells

About this item

Full title

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells

Publisher

England: BioMed Central

Journal title

BMC cancer, 2014-03, Vol.14 (1), p.146-146, Article 146

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Celastrol is a promising anti-tumor agent, yet it also elevates heat shock proteins (HSPs), especially HSP70, this effect believed to reduce its anti-tumor effects. Concurrent use of siRNA to increase celastrol's anti-tumor effects through HSP70 interference has been reported, but because siRNA technology is difficult to clinically apply, an altern...

Alternative Titles

Full title

Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3975845

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3975845

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/1471-2407-14-146

How to access this item